Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Eli Lilly › Douglas Kirk Ways
DW

Douglas Kirk Ways — 15 Patents

Eli Lilly: 14 patents #222 of 2,858Top 8%
JCJoslin Diabetes Center: 1 patents #34 of 88Top 40%
UNUnknown: 1 patents #29,356 of 83,584Top 40%
Johnson & Johnson: 1 patents #4,783 of 7,810Top 65%
Indianapolis, IN: #386 of 5,011 inventorsTop 8%
Indiana: #2,263 of 33,936 inventorsTop 7%
Overall (All Time): #307,048 of 4,157,543Top 8%
15 Patents All Time
Douglas Kirk Ways has been granted 15 US patents while listed as an inventor at Eli Lilly. The first was granted in 1998 and the most recent in December 2021. Douglas Kirk Ways ranks #307,048 of 4,157,543 US inventors in our database (top 7.4%). Patent records list Douglas Kirk Ways in Indianapolis, IN, US.

Patents per Year

Patents granted per year, 1998 to 2021Bar chart with a peak of 6 patents in 2000.peak 61998: 1 patents19981999: 1 patents19992000: 6 patents20002001: 5 patents20012002: 1 patents20022021: 1 patents2021

Issued Patents All Time

Showing 1–15 of 15 patents

Patent #TitleCo-InventorsDateApprox Value ⓘ
11207337 Co-therapy comprising canagliflozin and phentermine for the treatment of obesity and obesity related disorders Norman R. Rosenthal, Paul Rothenberg, David Polidori, Peter Stein 2021-12-28 $192,233,000
6486179 Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy Michael R. Jirousek, Lawrence E. Stramm 2002-11-26 $177,119,000
6291446 Therapeutic treatment for cytomegalovirus infection — 2001-09-18 $377,210,000
6288053 Use of protein kinase C inhibitors to enhance the clinical efficacy of radiation therapy Michael R. Jirousek, Lawrence E. Stramm 2001-09-11
6284751 Therapeutic treatment for VEGF related diseases Lloyd P. Aiello, Michael R. Jirousek, George L. King, Louis Vignati 2001-09-04 $196,428,000
6232299 Use of protein kinase C inhibitors to enhance the clinical efficacy of oncolytic agents and radiation therapy Michael R. Jirousek, Lawrence E. Stramm 2001-05-15 $406,429,000
6225301 Therapeutic treatment for renal dysfunction Richard Ernest Gilbert 2001-05-01 $1,234,894,000
6114320 Therapeutic treatment for VEGF related ocular diseases Lloyd P. Aiello, Michael R. Jirousek, George L. King, Louis Vignati 2000-09-05 $204,777,000
6107327 Therapeutic treatment for HIV infection Michael R. Jirousek, Lawrence E. Stramm 2000-08-22 $367,838,000
6103712 Therapeutic treatment for asthma — 2000-08-15 $127,345,000
6103713 Therapeutic treatment for autoimmune diseases Daniel Wierda 2000-08-15 $127,345,000
6093709 Therapeutic treatment for sexual dysfunctions Michael R. Jirousek, Lawrence E. Stramm 2000-07-25 $314,501,000
6093740 Therapeutic treatment for skin disorders Michael R. Jirousek, Lawrence E. Stramm, Louis Vignati 2000-07-25 $314,501,000
5962446 Therapetutic treatment for human T cell lymphotrophic virus type 1 infection Michael R. Jirousek, Lawrence E. Stramm 1999-10-05 $103,905,000
5723456 Therapeutic treatment for cardiovascular diseases Michael R. Jirousek, William F. Heath, Jr., Lawrence E. Stramm 1998-03-03 $243,063,000

Frequent Collaborators

Michael R. Jirousek10 shared
Lawrence E. Stramm8 shared
Louis Vignati3 shared
Lloyd P. Aiello2 shared
George L. King2 shared
Peter Stein1 shared

Nearby-Ranked Inventors

Naoya Kasahara15
Aaron Larry Snyder15
Avishay Meron15
Stuart Hatfield15
Satoshi KUNIYASU15
Ashton Mason15
Theodore Yuchiang Cheng15
Richard Sharbaugh15
Rajen Bhatt15